For example, in breast cancer, PTHrP promotes the proliferation of cancer cells as well as osteoclasts production; with the existence of IL-6, which is a potent stimulator of osteoclast formation, the effect of PTHrP on osteoclasts can be significantly enhanced, directly leading to increased osteolysis [31,32]. This evidence concerns the gene PTHLH and cancer.